The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products

Journal of the American Academy of Dermatology

Volumn 71, Issue 1, 2014, Pages 177-184

  Meckfessel, Matthew H ^a   Brandt, Staci ^a  

^a Galderma Laboratories LP   (United States)

Author keywords

ceramide; epidermal repair; skin barrier; skin care; skin disease

Indexed keywords

ACYL COENZYME A; CARBON; CERAMIDE; CERAMIDE 1; CERAMIDE 3; CERAMIDE DERIVATIVE; HYDROXYPALMITOYL SPHINGANINE; PALMITOYL COENZYME A; SERINE; SPHINGANINE; SPHINGOLIPID; SPHINGOLIPID E; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; BASEMENT MEMBRANE; CELL MEMBRANE; CREAM; DRUG HYDROXYLATION; DRUG MANUFACTURE; DRUG STRUCTURE; DRUG SYNTHESIS; EPIDERMIS; ESTERIFICATION; FATTY ACID DESATURATION; GAUCHER DISEASE; HUMAN; INTERCELLULAR SPACE; KERATINOCYTE; LOTION; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN CARE; SKIN DISEASE; STRATUM CORNEUM;

CERAMIDE; EPIDERMAL REPAIR; SKIN BARRIER; SKIN CARE; SKIN DISEASE;

CERAMIDES; DERMATITIS, ATOPIC; EPIDERMIS; GAUCHER DISEASE; HUMANS; PSORIASIS; SKIN CARE; SKIN DISEASES;

EID: 84903269864     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.01.891     Document Type: Review

References (51)

1. P.M. Elias, and G.K. Menon Structural and lipid biochemical correlates of the epidermal permeability barrier Adv Lipid Res 24 1991 1 26
2. J.Q. Del Rosso, and J. Levin Clinical relevance of maintaining the structural and functional integrity of the stratum corneum: why is it important to you? J Drugs Dermatol 10 Suppl 2011 S5 12
3. C.R. Harding The stratum corneum: structure and function in health and disease Dermatol Ther 17 Suppl 2004 6 15
4. E. Proksch, J.M. Brandner, and J.M. Jensen The skin: an indispensable barrier Exp Dermatol 17 2008 1063 1072
5. G. Imokawa, S. Akasaki, M. Hattori, and N. Yoshizuka Selective recovery of deranged water-holding properties by stratum corneum lipids J Invest Dermatol 87 1986 758 761
6. M. Farwick, P. Lersch, B. Santonnat, K. Korevaar, and A.V. Rawlings Developments in ceramide identification, synthesis, function, and nomenclature Cosmet Toiletries 124 2009 63 72
7. European Commission-Enterprise and Industry Directorate General Consumer Goods. INCI-nomenclature conventions. 2006. Available from: URL: http://www.surfatech.com/pdfs/INCI-Names.pdf. Accessed October 25, 2013.
8. P.W. Wertz, M.C. Miethke, S.A. Long, J.S. Strauss, and D.T. Downing The composition of the ceramides from human stratum corneum and from comedones J Invest Dermatol 84 1985 410 412
9. Y. Masukawa, H. Narita, H. Sato, A. Naoe, N. Kondo, and Y. Sugai et al. Comprehensive quantification of ceramide species in human stratum corneum J Lipid Res 50 2009 1708 1719
10. J. van Smeden, L. Hoppel, R. van der Heijden, T. Hankemeier, R.J. Vreeken, and J.A. Bouwstra LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery J Lipid Res 52 2011 1211 1221
11. Y. Masukawa, H. Narita, E. Shimizu, N. Kondo, Y. Sugai, and T. Oba et al. Characterization of overall ceramide species in human stratum corneum J Lipid Res 49 2008 1466 1476
12. L. Norlen, I. Nicander, A. Lundsjo, T. Cronholm, and B. Forslind A new HPLC-based method for the quantitative analysis of inner stratum corneum lipids with special reference to the free fatty acid fraction Arch Dermatol Res 290 1998 508 516
13. T.D. Mullen, Y.A. Hannun, and L.M. Obeid Ceramide synthases at the centre of sphingolipid metabolism and biology Biochem J 441 2012 789 802
14. Y. Mizutani, S. Mitsutake, K. Tsuji, A. Kihara, and Y. Igarashi Ceramide biosynthesis in keratinocyte and its role in skin function Biochimie 91 2009 784 790
15. A.H. Merrill Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway J Biol Chem 277 2002 25843 25846
16. M. Levy, and A.H. Futerman Mammalian ceramide synthases IUBMB Life 62 2010 347 356
17. Y. Mizutani, A. Kihara, H. Chiba, H. Tojo, and Y. Igarashi 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length J Lipid Res 49 2008 2356 2364
18. Y. Uchida, M. Hara, H. Nishio, E. Sidransky, S. Inoue, and F. Otsuka et al. Epidermal sphingomyelins are precursors for selected stratum corneum ceramides J Lipid Res 41 2000 2071 2082
19. W.M. Holleran, Y. Takagi, G.K. Menon, G. Legler, K.R. Feingold, and P.M. Elias Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function J Clin Invest 91 1993 1656 1664
20. W.M. Holleran, E.I. Ginns, G.K. Menon, J.U. Grundmann, M. Fartasch, and C.E. McKinney et al. Consequences of beta-glucocerebrosidase deficiency in epidermis: ultrastructure and permeability barrier alterations in Gaucher disease J Clin Invest 93 1994 1756 1764
21. R. Jennemann, M. Rabionet, K. Gorgas, S. Epstein, A. Dalpke, and U. Rothermel et al. Loss of ceramide synthase 3 causes lethal skin barrier disruption Hum Mol Genet 21 2012 586 608
22. E. Sidransky Gaucher disease: insights from a rare Mendelian disorder Discov Med 14 2012 273 281
23. G.A. Grabowski Gaucher disease and other storage disorders Hematology Am Soc Hematol Educ Program 2012 2012 13 18
24. E. Sidransky, M. Fartasch, R.E. Lee, L.A. Metlay, S. Abella, and A. Zimran et al. Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease Pediatr Res 39 1996 134 141
25. A. Chan, W.M. Holleran, T. Ferguson, D. Crumrine, O. Goker-Alpan, and R. Schiffmann et al. Skin ultrastructural findings in type 2 Gaucher disease: diagnostic implications Mol Genet Metab 104 2011 631 636
26. S. Motta, M. Monti, S. Sesana, L. Mellesi, R. Ghidoni, and R. Caputo Abnormality of water barrier function in psoriasis: role of ceramide fractions Arch Dermatol 130 1994 452 456
27. S. Motta, M. Monti, S. Sesana, R. Caputo, S. Carelli, and R. Ghidoni Ceramide composition of the psoriatic scale Biochim Biophys Acta 1182 1993 147 151
28. F. Alessandrini, S. Stachowitz, J. Ring, and H. Behrendt The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris J Invest Dermatol 116 2001 394 400
29. T. Doering, W.M. Holleran, A. Potratz, G. Vielhaber, P.M. Elias, and K. Suzuki et al. Sphingolipid activator proteins are required for epidermal permeability barrier formation J Biol Chem 274 1999 11038 11045
30. T.E. Shaw, G.P. Currie, C.W. Koudelka, and E.L. Simpson Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health J Invest Dermatol 131 2011 67 73
31. J.L. Sugarman The epidermal barrier in atopic dermatitis Semin Cutan Med Surg 27 2008 108 114
32. C. Flohr, K. England, S. Radulovic, W.H. McLean, L.E. Campbel, and J. Barker et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age Br J Dermatol 163 2010 1333 1336
33. G.M. O'Regan, P.M. Kemperman, A. Sandilands, H. Chen, L.E. Campbell, and K. Kroboth et al. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes J Allergy Clin Immunol 126 2010 574-80.e1
34. J.M. Jungersted, H. Scheer, M. Mempel, H. Baurecht, L. Cifuentes, and J.K. Hogh et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema Allergy 65 2010 911 918
35. I. Jakasa, E.S. Koster, F. Calkoen, W.H. McLean, L.E. Campbell, and J.D. Bos et al. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations J Invest Dermatol 131 2011 540 542
36. G. Imokawa, A. Abe, K. Jin, Y. Higaki, M. Kawashima, and A. Hidano Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 96 1991 523 526
37. J. Ishikawa, H. Narita, N. Kondo, M. Hotta, Y. Takagi, and Y. Masukawa et al. Changes in the ceramide profile of atopic dermatitis patients J Invest Dermatol 130 2010 2511 2514
38. M. Janssens, J. van Smeden, G.S. Gooris, W. Bras, G. Portale, and P.J. Caspers et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients J Lipid Res 53 2012 2755 2766
39. C.Y. Cui, S. Kusuda, T. Seguchi, M. Takahashi, K. Aisu, and T. Tezuka Decreased level of prosaposin in atopic skin J Invest Dermatol 109 1997 319 323
40. J. Hara, K. Higuchi, R. Okamoto, M. Kawashima, and G. Imokawa High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis J Invest Dermatol 115 2000 406 413
41. J.A. Bouwstra, G.S. Gooris, F.E. Dubbelaar, A.M. Weerheim, A.P. Ijzerman, and M. Ponec Role of ceramide 1 in the molecular organization of the stratum corneum lipids J Lipid Res 39 1998 186 196
42. I. Castiel-Higounenc, C. Ferraris, A. Lavalle, M. Philippe, Q. Gaetani, and R. Schmidt Exogenous sphinganin derived sphingolipid increases epidermal ceramide content in human reconstructed skin Nouv Dermatol 18 1999 541 546
43. E. Simpson, and Y. Dutronc A new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adults J Drugs Dermatol 10 2011 744 749
44. E. Simpson, N.S. Trookman, R.L. Rizer, N. Preston, L.E. Colon, and L.A. Johnson et al. Safety and tolerability of a body wash and moisturizer when applied to infants and toddlers with a history of atopic dermatitis: results from an open-label study Pediatr Dermatol 29 2012 590 597
45. E.S. Schorr, F. Sidou, and N. Kerrouche Adjunctive use of a facial moisturizer SPF 30 containing ceramide precursor improves tolerability of topical tretinoin 0.05%: a randomized, investigator-blinded, split-face study J Drugs Dermatol 11 2012 1104 1107
46. E. Simpson, A. Bohling, S. Bielfeldt, C. Bosc, and N. Kerrouche Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor J Dermatolog Treat 24 2013 122 125
47. H.C. Huang, and T.M. Chang Ceramide 1 and ceramide 3 act synergistically on skin hydration and the transepidermal water loss of sodium lauryl sulfate-irritated skin Int J Dermatol 47 2008 812 819
48. Z.D. Draelos The effect of ceramide-containing skin care products on eczema resolution duration Cutis 81 2008 87 91
49. K. Wiren, C. Nohlgard, F. Nyberg, L. Holm, M. Svensson, and A. Johannesson et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial J Eur Acad Dermatol Venereol 23 2009 1267 1272
50. G. Imokawa, S. Akasaki, A. Kawamata, S. Yano, and N. Takaishi Water-retaining function in the stratum corneum and its recovery properties by synthetic pseudoceramides J Soc Cosmet Chem 40 1989 273 285
51. G. Imokawa, Y. Yada, K. Higuchi, M. Okuda, Y. Ohashi, and A. Kawamata Pseudo-acylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid-deficient rats and has an inhibitory effect on epidermal hyperplasia J Clin Invest 94 1994 89 96